The Spectrum of Eye Disease in Hospitalized Adults Living with HIV, 1995–2010

Miller, Christopher P.; Short, William R.; Perez-Povis, Lorena; Lontok, Josephine; Fecarotta, Christopher; Liu, Mengdan; Sendecki, Jocelyn; Belden, Katherine

doi:10.1089/apc.2013.0258

Cited by 7 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ART therapy targets several aspects of HIV replication. As these therapies have evolved, ART treatment can be differentiated into two eras, era I (1996–2001) and era II (after 2002) 7–10 . The current classes of drugs in antiretroviral therapies include: nucleoside reverse transcriptase inhibitors (NRTIs), non‐nucleoside reverse transcription inhibitors (NNRTIs), protease inhibitors (PIs), and integrase inhibitors (INSTIs).…”

Section: Introductionmentioning

confidence: 99%

“…As these therapies have evolved, ART treatment can be differentiated into two eras, era I (1996–2001) and era II (after 2002). 7 , 8 , 9 , 10 The current classes of drugs in antiretroviral therapies include: nucleoside reverse transcriptase inhibitors (NRTIs), non‐nucleoside reverse transcription inhibitors (NNRTIs), protease inhibitors (PIs), and integrase inhibitors (INSTIs). The most commonly used regimens currently include two NRTIs plus an INSTI.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV

Qing

Chan

et al. 2023

Cancer Medicine

View full text Add to dashboard Cite

The introduction of highly active antiretroviral therapy (HAART or ART) in the mid-1990s, has reduced the number of deaths from AIDS, and increased overall survival. People living with HIV (PLWH) are living much longer and the number of older individuals living with HIV is increasing. In 2019, an estimated 45% of Americans living with HIV were aged 55 and older, 27% were aged 60 and older, and 6% were aged 70 and older. 1 Though ART lowered the risks of developing AIDS-defining cancers, including Kaposi's sarcoma and non-Hodgkin lymphoma (NHL), the incidence of non-AIDS-defining cancers (NADCs) rose by more than threefold. 2,3 Clinical epidemiologic research also suggests a higher prevalence of other age-associated comorbidities in PLWH. These include earlier onset cardiovascular disease, bone fractures, osteoporosis, kidney and liver disease, cognitive decline, and frailty. [4][5][6] ART therapy targets several aspects of HIV replication. As these therapies have evolved, ART treatment can be

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV

Qing

Chan

et al. 2023

Cancer Medicine

View full text Add to dashboard Cite

show abstract

Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment

Stewart

2017

Curr Infect Dis Rep

View full text Add to dashboard Cite

The introduction of highly active antiretroviral therapy (HAART) in 1996 changed ophthalmologic findings from predominantly acute infectious diseases to chronic, slowly progressive, debilitating conditions. HIV-associated neuroretinal disorder infrequently leads to blindness, but it causes visual disability in a large percentage of patients. Cytomegalovirus retinitis is now seen less commonly in the USA, but it remains an important cause of blindness in HIV-infected patients from developing countries. Immune recovery uveitis has emerged as a major cause of visual disability in the USA. As HIV has become a chronic disease, visual disability due to chronic noninfectious diseases have become increasingly important.

show abstract

Predictores sociodemográficos asociados al espectro de enfermedad neurorretiniana no oportunista de etiología no infecciosa en pacientes con VIH/SIDA: revisión integrativa

Gómez-Gualdrón

Sánchez-Uzcátegui

Camacho

2022

Archivos de la Sociedad Española de Oftalmología

View full text Add to dashboard Cite

The Spectrum of Eye Disease in Hospitalized Adults Living with HIV, 1995–2010

Cited by 7 publications

References 19 publications

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV

Ophthalmologic Disease in HIV Infection: Recent Changes in Pathophysiology and Treatment

Predictores sociodemográficos asociados al espectro de enfermedad neurorretiniana no oportunista de etiología no infecciosa en pacientes con VIH/SIDA: revisión integrativa

Contact Info

Product

Resources

About